(Q37178648)

English

Clinical and immunologic effects of intranodal autologous tumor lysate-dendritic cell vaccine with Aldesleukin (Interleukin 2) and IFN-{alpha}2a therapy in metastatic renal cell carcinoma patients

scientific article published on 21 July 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 August 2017

Clinical and immunologic effects of intranodal autologous tumor lysate-dendritic cell vaccine with Aldesleukin (Interleukin 2) and IFN-{alpha}2a therapy in metastatic renal cell carcinoma patients (English)

1 reference

Europe PubMed Central

18 August 2017

0 references

1 reference

based on heuristic

inferred from title

renal cell carcinoma

1 reference

based on heuristic

inferred from title

metastatic renal cell carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

object named as

Benita Wolf

3

0 references

author name string

Thomas Schwaab

1

1 reference

Europe PubMed Central

18 August 2017

Adrian Schwarzer

2

1 reference

Europe PubMed Central

18 August 2017

Todd S Crocenzi

4

1 reference

Europe PubMed Central

18 August 2017

John D Seigne

5

1 reference

Europe PubMed Central

18 August 2017

Nancy A Crosby

6

1 reference

Europe PubMed Central

18 August 2017

Bernard F Cole

7

1 reference

Europe PubMed Central

18 August 2017

Jan L Fisher

8

1 reference

Europe PubMed Central

18 August 2017

Jill C Uhlenhake

9

1 reference

Europe PubMed Central

18 August 2017

Diane Mellinger

10

1 reference

Europe PubMed Central

18 August 2017

Cathy Foster

11

1 reference

Europe PubMed Central

18 August 2017

Zbigniew M Szczepiorkowski

12

1 reference

Europe PubMed Central

18 August 2017

Susan M Webber

13

1 reference

Europe PubMed Central

18 August 2017

Alan R Schned

14

1 reference

Europe PubMed Central

18 August 2017

Robert D Harris

15

1 reference

Europe PubMed Central

18 August 2017

Richard J Barth

16

1 reference

Europe PubMed Central

18 August 2017

John A Heaney

17

1 reference

Europe PubMed Central

18 August 2017

Randolph J Noelle

18

1 reference

Europe PubMed Central

18 August 2017

Marc S Ernstoff

19

1 reference

Europe PubMed Central

18 August 2017

language of work or name

0 references

publication date

21 July 2009

1 reference

Europe PubMed Central

18 August 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

Clinical Cancer Research

1 reference

Europe PubMed Central

18 August 2017

15

1 reference

Europe PubMed Central

18 August 2017

15

1 reference

Europe PubMed Central

18 August 2017

4986-4992

1 reference

Europe PubMed Central

18 August 2017

Developing a rational tumor vaccine therapy for renal cell carcinoma: immune yin and yang

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3775650

6 September 2017

A phase I trial of vaccination of CA9-derived peptides for HLA-A24-positive patients with cytokine-refractory metastatic renal cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3775650

6 September 2017

A nonclassical non-Valpha14Jalpha18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3775650

6 September 2017

Dendritic cells strongly boost the antitumor activity of adoptively transferred T cells in vivo.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3775650

6 September 2017

Forecasting the cytokine storm following systemic interleukin (IL)-2 administration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3775650

6 September 2017

Dendritic cell immunotherapy: mapping the way.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3775650

6 September 2017

Tumor immunity meets autoimmunity: antigen levels and dendritic cell maturation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3775650

6 September 2017

Intranodal Administration of Peptide-Pulsed Mature Dendritic Cell Vaccines Results in Superior CD8+T-Cell Function in Melanoma Patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3775650

6 September 2017

A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3775650

6 September 2017

CD4+CD25+ suppressor lymphocytes in the circulation of patients immunized against melanoma antigens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3775650

6 September 2017

Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3775650

6 September 2017

Dendritic cells and the control of immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3775650

6 September 2017

Mig and IP-10: CXC chemokines that target lymphocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3775650

6 September 2017

The dendritic cell system and its role in immunogenicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3775650

6 September 2017

Provision of 4-1BB ligand enhances effector and memory CTL responses generated by immunization with dendritic cells expressing a human tumor-associated antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3775650

14 September 2017

Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3775650

26 June 2018

Human renal cell carcinoma antigen-specific CTLs: antigen-driven selection and long-term persistence in vivo.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3775650

26 June 2018

Characterization of a Human Renal Cell Carcinoma Specific Cytotoxic CD8+ T Cell Line

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3775650

26 June 2018

Phase I/II study of immunotherapy using autologous tumor lysate-pulsed dendritic cells in patients with metastatic renal cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3775650

3 September 2018

Favorable prognosis of renal cell carcinoma with increased expression of chemokines associated with a Th1-type immune response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3775650

3 September 2018

Prognostic significance of autoimmunity during treatment of melanoma with interferon.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3775650

3 September 2018

Impaired cytolytic activity in peripheral blood T cells from renal cell carcinoma patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3775650

3 September 2018

IL-2 overcomes the unresponsiveness but fails to reverse the regulatory function of antigen-induced T regulatory cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3775650

3 September 2018

Kinase inhibition with BAY 43-9006 in renal cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3775650

3 September 2018

Randomized phase II study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3775650

3 September 2018

Interleukin-2- and interferon alfa-2a-based immunochemotherapy in advanced renal cell carcinoma: a Prospectively Randomized Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3775650

3 September 2018

Use of cell-tracking dyes to determine proliferation precursor frequencies of antigen-specific T cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3775650

3 September 2018

Decreased antigen presentation by dendritic cells in patients with breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3775650

3 September 2018

Adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 in patients with metastatic malignant melanoma and renal cell carcinoma: a pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19622576

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intranodal immunization with tumor lysate-pulsed dendritic cells enhances protective antitumor immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/19622576

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase IA trial of sequential administration recombinant DNA-produced interferons: combination recombinant interferon gamma and recombinant interferon alfa in patients with metastatic renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19622576

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized phase II trial comparing two different sequence combinations of autologous vaccine and human recombinant interferon gamma and human recombinant interferon alpha2B therapy in patients with metastatic renal cell carcinoma: clinical outcom

1 reference

https://pubmed.ncbi.nlm.nih.gov/19622576

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Minimal recruitment and activation of dendritic cells within renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19622576

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Self-recognition and tumor response to immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19622576

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal cell carcinomas produce IL-6, IL-10, IL-11, and TGF-beta 1 in primary cultures and modulate T lymphocyte blast transformation

1 reference

https://pubmed.ncbi.nlm.nih.gov/19622576

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autoimmunity as a prognostic factor in melanoma patients treated with adjuvant low-dose interferon alpha

1 reference

https://pubmed.ncbi.nlm.nih.gov/19622576

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon alpha augments activation-induced T cell death by upregulation of Fas (CD95/APO-1) and Fas ligand expression

1 reference

https://pubmed.ncbi.nlm.nih.gov/19622576

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo description of dendritic cells in human renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19622576

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preliminary analysis of patients with progressive renal cell carcinoma vaccinated with CA9-peptide-pulsed mature dendritic cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/19622576

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low levels of interferon-alpha induce CD86 (B7.2) expression and accelerates dendritic cell maturation from human peripheral blood mononuclear cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/19622576

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized phase II trial of high-dose interleukin-2 either alone or in combination with interferon alfa-2b in advanced renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19622576

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma. Groupe Français d'Immunothérapie

1 reference

https://pubmed.ncbi.nlm.nih.gov/19622576

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of cytokine therapy on survival for patients with advanced renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19622576

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of malignant melanoma and renal cell carcinoma with recombinant human interleukin-2: analysis of cytokine levels in sera and culture supernatants

1 reference

https://pubmed.ncbi.nlm.nih.gov/19622576

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vaccine therapy for renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19622576

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An optimized method for the functional analysis of human regulatory T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/19622576

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1158/1078-0432.CCR-08-3240

1 reference

Europe PubMed Central

18 August 2017

1 reference

Europe PubMed Central

18 August 2017

1 reference

Europe PubMed Central

18 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37178648&oldid=1790163393"